D Giuffrida

Summary

Publications

  1. pmc New treatment in advanced thyroid cancer
    Dario Giuffrida
    Department of Medical Oncology, Mediterranean Institut of Oncology, Via Penninazzo, 7, 95029 Viagrande, Italy
    J Oncol 2012:391629. 2012
  2. ncbi Thyroid carcinosarcoma, a rare and aggressive histotype: a case report
    D Giuffrida
    Department of Oncology, Ospedale S Luigi S Currò, Catania, Italy
    Ann Oncol 11:1497-9. 2000
  3. ncbi [Anaplastic carcinoma of the thyroid: diagnosis and treatment]
    D Giuffrida
    Divisione di Oncologia Medica, Ospedale S Luigi, Azienda Ospedaliera Garibaldi S Luigi Currò Ascoli Tomaselli, Viale Fleming 24, 95100 Catania, Italia
    Clin Ter 152:255-61. 2001
  4. ncbi Differentiated thyroid cancer in children and adolescents
    D Giuffrida
    Medical Oncology Unit, S Luigi Hospital, University of Catania, Italy
    J Endocrinol Invest 25:18-24. 2002
  5. ncbi Metastasis to the thyroid gland: a case report and review of the literature
    D Giuffrida
    Division of Medical Oncology, S Luigi Hospital, Catania, Italy
    J Endocrinol Invest 26:560-3. 2003
  6. ncbi Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer
    G Pellegriti
    Istituto di Medicina Interna e Malattie Endocrine e del Metabolismo, University of Catania Medical School, Ospedale Garibaldi, Catania, Italy
    Thyroid 11:1025-30. 2001
  7. ncbi Cardiac metastasis from primary anaplastic thyroid carcinoma: report of three cases and a review of the literature
    D Giuffrida
    Division of Medical Oncology, Ospedale San Luigi, Az. Osp. 'Garibaldi, Catania, Italy
    Endocr Relat Cancer 8:71-3. 2001
  8. ncbi Fludarabine phosphate as an active and well tolerated salvage therapy in an elderly heavily pretreated Hodgkin's disease patient: a case report
    R Bordonaro
    Division of Medical Oncology, , Catania, Italy
    Tumori 85:288-9. 1999
  9. doi Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
    Giulio Metro
    Division of Medical Oncology, Azienda Ospedaliera Santa Maria della Misericordia, Via Dottori 1, 06156 Perugia, Italy
    Cancer Chemother Pharmacol 68:1405-12. 2011

Collaborators

  • H Gharib
  • A Belfiore
  • M Ursino
  • Giulio Metro
  • G Pellegriti
  • R Chiari
  • M J Fischer
  • M Mare
  • M Meacci
  • L Pistola
  • R Bellavita
  • D Giannarelli
  • V Ludovini
  • F R Tofanetti
  • M Ferraldeschi
  • C Bennati
  • V Minotti
  • L Crino
  • L Marcomigni
  • R Bordonaro
  • S Squatrito
  • C Scollo
  • R Vigneri
  • V Pezzino
  • D Priolo
  • G Failla
  • P Colina

Detail Information

Publications9

  1. pmc New treatment in advanced thyroid cancer
    Dario Giuffrida
    Department of Medical Oncology, Mediterranean Institut of Oncology, Via Penninazzo, 7, 95029 Viagrande, Italy
    J Oncol 2012:391629. 2012
    ..Reported data in this paper are encouraging, but further trials are necessary to obtain a more effective result in thyroid carcinoma treatment...
  2. ncbi Thyroid carcinosarcoma, a rare and aggressive histotype: a case report
    D Giuffrida
    Department of Oncology, Ospedale S Luigi S Currò, Catania, Italy
    Ann Oncol 11:1497-9. 2000
    ..Carcinosarcoma of the thyroid is a very aggressive tumor with a clinical course similar to anaplastic thyroid carcinoma. Survival is very short despite aggressive multimodal treatment...
  3. ncbi [Anaplastic carcinoma of the thyroid: diagnosis and treatment]
    D Giuffrida
    Divisione di Oncologia Medica, Ospedale S Luigi, Azienda Ospedaliera Garibaldi S Luigi Currò Ascoli Tomaselli, Viale Fleming 24, 95100 Catania, Italia
    Clin Ter 152:255-61. 2001
    ..Survival rates however remain low. Despite intense applications of such integrated therapy, no standardized successful treatment protocol has yet been established...
  4. ncbi Differentiated thyroid cancer in children and adolescents
    D Giuffrida
    Medical Oncology Unit, S Luigi Hospital, University of Catania, Italy
    J Endocrinol Invest 25:18-24. 2002
    ..For this reason, although the prognosis is usually good in these patients, we believe that total or near total thyroidectomy with lymphadenectomy is always the required initial surgical treatment...
  5. ncbi Metastasis to the thyroid gland: a case report and review of the literature
    D Giuffrida
    Division of Medical Oncology, S Luigi Hospital, Catania, Italy
    J Endocrinol Invest 26:560-3. 2003
    ..In this report, we present a case of renal carcinoma with thyroid metastases and a review of the literature...
  6. ncbi Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer
    G Pellegriti
    Istituto di Medicina Interna e Malattie Endocrine e del Metabolismo, University of Catania Medical School, Ospedale Garibaldi, Catania, Italy
    Thyroid 11:1025-30. 2001
    ..Its efficacy to treat advanced metastatic disease should be further investigated...
  7. ncbi Cardiac metastasis from primary anaplastic thyroid carcinoma: report of three cases and a review of the literature
    D Giuffrida
    Division of Medical Oncology, Ospedale San Luigi, Az. Osp. 'Garibaldi, Catania, Italy
    Endocr Relat Cancer 8:71-3. 2001
    ..CONCLUSIONS: Anaplastic thyroid cancer is an aggressive cancer with a dismal prognosis. It should be borne in mind as a source of cardiac metastasis and a cause of cardiac death...
  8. ncbi Fludarabine phosphate as an active and well tolerated salvage therapy in an elderly heavily pretreated Hodgkin's disease patient: a case report
    R Bordonaro
    Division of Medical Oncology, , Catania, Italy
    Tumori 85:288-9. 1999
    ..The duration of clinical remission and systemic symptom palliation was 9 and 11 months, respectively. Further evaluation of fludarabine phosphate as salvage therapy in relapsed/refractory elderly Hodgkin's disease patients is needed...
  9. doi Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
    Giulio Metro
    Division of Medical Oncology, Azienda Ospedaliera Santa Maria della Misericordia, Via Dottori 1, 06156 Perugia, Italy
    Cancer Chemother Pharmacol 68:1405-12. 2011
    ..Also, single nucleotide polymorphisms (SNPs) at the XRCC3, XPD, ERCC1, GARFT, DHFR, and TS genes were investigated...